SEQ_NO | 2 | Date of announcement | 2025/01/21 | Time of announcement | 17:33:29 |
Subject | Announcement in accordance with Article 22.1(3) of the Regulations Governing Loaning of Funds and Making of Endorsements/Guarantees by Public Companies | ||||
Date of events | 2025/01/21 | To which item it meets | paragraph 23 | ||
Statement | 1.Date of occurrence of the event:2025/01/21 2.Funding recipient (1)Name(2)Relationship with lender (3)Lending limit (thousand NTD)(4)Starting outstanding balance (thousand NTD)(5)New loan (thousand NTD)(6)Is it part of a scheduled allocation or revolving limit for the same recipient that the chairman is authorized by the board of directors to allocate(7)Outstanding balance (thousand NTD) up to the date of occurrence (8)Reason for new loan (thousand NTD): (1)Name?GPMC (2)Relationship with lender?GPMC is a subsidiary of Medeon Biodesign which holds 89.27% of the shares. (3)Lending limit (thousand NTD)?G171,983 (4)Starting outstanding balance (thousand NTD)?G0 (5)New loan (thousand NTD)?G165,000 (6)Is it part of a scheduled allocation or revolving limit for the same recipient that the chairman is authorized by the board of directors to allocate?GYes (7)Outstanding balance (thousand NTD) up to the date of occurrence?G 165,000 (8)Reason for new loan (thousand NTD)?Gworking capital requirements 3.For collaterals provided by the loan recipient, the (1)Content(2)Value (thousand NTD): (1)Content?GNone (2)Value (thousand NTD)?G0 4.For the latest financial reports of the loan recipient, the (1)Capital (thousand NTD)(2)Cumulative gains/losses (thousand NTD): (1)Capital (thousand NTD)?G111,890 (2)Cumulative gains/losses (thousand NTD)?G-1,187,638 5.Method of calculation of interest:With an annual interest rate of 3% 6.For repayment, the(1)Condition(2)Date: (1)Condition?GBased on the contract (2)Date?GBased on the contract 7.The amount of monetary loans extended to others as of the date of occurrence (thousand NTD):165,000 8.The total amount of monetary loans extended to others as a percentage of the public company’s net worth on the latest financial statements as of the date of occurrence:9.59% 9.Sources of funds for the company to extend monetary loans to others:Other 10.Any other matters that need to be specified: The source of funds loaned by the Company to PMC is working capital. |